A role for phosphodiesterase type-4 inhibitors in COPD?
Johnson
D C
DC
Pulmonary and Critical Care Unit, Massachusetts General Hospital, Boston, MA 02114, USA. djohnson5@partners.org
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000235:genetics / Q000628:therapy; D016540:Smoking Cessation
D001993:Bronchodilator Agents; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4